Deep brain stimulation in Parkinson's disease: A multicentric, long-term, observational pilot study.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Oct 2019
Historique:
received: 20 11 2018
revised: 14 04 2019
accepted: 23 07 2019
pubmed: 3 9 2019
medline: 15 9 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

The impact of deep brain stimulation (DBS) on cognitive and urinary disorders, falls, and eventually hospitalizations and mortality in Parkinson's disease (PD) is still debated. We compared the rates of dementia, mild cognitive impairment (MCI), urinary incontinence, nocturia, falls, hospitalizations, and mortality in a cohort of PD patients undergoing DBS with a cohort of medically-treated patients chosen as controls. We conducted a retrospective pilot study in six Italian DBS centers. 91 PD patients receiving DBS and 91 age- and gender-matched controls receiving the best medical treatment alone with a minimum follow-up of one year were enrolled. Clinical data were collected from baseline to the last follow-up visit using an ad-hoc developed web-based system. The risk of dementia was similar in the two groups while patients in the surgical cohort had lower rates of MCI, urinary incontinence, nocturia, and falls. In contrast, the risk of hospital admissions related to PD was higher in the surgical cohort. However, when excluding hospitalizations related to DBS surgery, the difference between the two cohorts was not significant. The surgical cohort had a lower number of hospitalizations not related to PD. The risk of death was similar in the two groups. Despite a higher risk of hospitalization, patients receiving DBS had a lower rate of MCI, urinary incontinence, nocturia and falls, without evidence of an increased risk of dementia and mortality. Although these findings need to be confirmed in prospective studies, they seem to suggest that DBS may play a significant role in the management of non-motor symptoms and common complications of advanced PD.

Sections du résumé

BACKGROUND BACKGROUND
The impact of deep brain stimulation (DBS) on cognitive and urinary disorders, falls, and eventually hospitalizations and mortality in Parkinson's disease (PD) is still debated.
OBJECTIVE OBJECTIVE
We compared the rates of dementia, mild cognitive impairment (MCI), urinary incontinence, nocturia, falls, hospitalizations, and mortality in a cohort of PD patients undergoing DBS with a cohort of medically-treated patients chosen as controls.
METHODS METHODS
We conducted a retrospective pilot study in six Italian DBS centers. 91 PD patients receiving DBS and 91 age- and gender-matched controls receiving the best medical treatment alone with a minimum follow-up of one year were enrolled. Clinical data were collected from baseline to the last follow-up visit using an ad-hoc developed web-based system.
RESULTS RESULTS
The risk of dementia was similar in the two groups while patients in the surgical cohort had lower rates of MCI, urinary incontinence, nocturia, and falls. In contrast, the risk of hospital admissions related to PD was higher in the surgical cohort. However, when excluding hospitalizations related to DBS surgery, the difference between the two cohorts was not significant. The surgical cohort had a lower number of hospitalizations not related to PD. The risk of death was similar in the two groups.
CONCLUSION CONCLUSIONS
Despite a higher risk of hospitalization, patients receiving DBS had a lower rate of MCI, urinary incontinence, nocturia and falls, without evidence of an increased risk of dementia and mortality. Although these findings need to be confirmed in prospective studies, they seem to suggest that DBS may play a significant role in the management of non-motor symptoms and common complications of advanced PD.

Identifiants

pubmed: 31476620
pii: S0022-510X(19)30332-6
doi: 10.1016/j.jns.2019.07.029
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

116411

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Emma Scelzo (E)

"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan and Fondazione IRCCS Ca' Granda - Ospedale Maggiore, Milan, Italy.

Ettore Beghi (E)

Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri IRCCS, Milan, Italy.

Manuela Rosa (M)

"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan and Fondazione IRCCS Ca' Granda - Ospedale Maggiore, Milan, Italy.

Serena Angrisano (S)

Department of Neuroscience, University of Turin, Italy.

Angelo Antonini (A)

Department of Neuroscience (DNS), University of Padua, Italy.

Caterina Bagella (C)

Movement Disorder Unit, Department of Clinical Neurosciences, IRCCS Carlo Besta Neurological Institute, Milan, Italy.

Elisa Bianchi (E)

Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri IRCCS, Milan, Italy.

Elena Caputo (E)

Department of Neurology, "F. Miulli" General Hospital, Acquaviva delle Fonti, Italy.

Francesco Lena (F)

Department of Neurology, Parkinson's Center, IRCCS Neuromed, Pozzilli, Italy.

Leonardo Lopiano (L)

Department of Neuroscience, University of Turin, Italy.

Andrea Marcante (A)

Parkinson Unit, IRCCS San Camillo Hospital, Venice, Italy.

Sara Marceglia (S)

"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan and Fondazione IRCCS Ca' Granda - Ospedale Maggiore, Milan, Italy; Department of Engineering and Architecture, University of Trieste, Trieste, Italy.

Francesco Massaro (F)

Department of Neurology, "F. Miulli" General Hospital, Acquaviva delle Fonti, Italy.

Nicola Modugno (N)

Department of Neurology, Parkinson's Center, IRCCS Neuromed, Pozzilli, Italy.

Claudio Pacchetti (C)

Parkinson and movement disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Manuela Pilleri (M)

Department of Neurology, Villa Margherita, Private clinic, Arcugnano, Vicenza, Italy.

Nicolo Gabriele Pozzi (NG)

Parkinson and movement disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Luigi Michele Romito (LM)

Movement Disorder Unit, Department of Clinical Neurosciences, IRCCS Carlo Besta Neurological Institute, Milan, Italy.

Marco Santilli (M)

Department of Neurology, Parkinson's Center, IRCCS Neuromed, Pozzilli, Italy.

Filippo Tamma (F)

Department of Neurology, "F. Miulli" General Hospital, Acquaviva delle Fonti, Italy.

Luca Weis (L)

Parkinson Unit, IRCCS San Camillo Hospital, Venice, Italy.

Maurizio Zibetti (M)

Department of Neuroscience, University of Turin, Italy.

Alberto Priori (A)

"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan and Fondazione IRCCS Ca' Granda - Ospedale Maggiore, Milan, Italy; Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy. Electronic address: alberto.priori@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH